Streetbeat News

Products Services

KOPN

Kopin Corporation (NASDAQ:KOPN) announced significant progress in establishing a 'fabless' OLED display production for defense applications, including forming a partnership in a NATO-member European country and achieving near-zero degradation in brightness performance in initial life testing. The company's strategy focuses on agility and cost-effectiveness by relying on partners for fabrication and deposition, aiming to complete the transition by 2024.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:19 pm

Recent options activity for Philip Morris Intl (NYSE:PM) shows a bearish sentiment among investors, with 77% of trades being bearish. The trades range from $60.0 to $110.0 strike prices, indicating expected price movements within this range over the next three months. The company, known for its tobacco products and recent diversifications, is currently trading at $94.67, with a potential overbought status as indicated by RSI readings. Its next earnings release is anticipated in 42 days.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 8:15 pm

SKIN

The Beauty Health Company (NASDAQ:SKIN), known for its flagship brand Hydrafacial, has officially appointed Marla Beck as its President and CEO. Beck, who has been serving as Interim CEO since November 20, 2023, and is a member of the Board of Directors, brings extensive experience from her time as the founder and CEO of Bluemercury. Her leadership is expected to drive growth and value for BeautyHealth, leveraging her deep understanding of the beauty industry and track record of building successful brands.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:07 pm

MDXH

MDxHealth SA (NASDAQ:MDXH) has introduced a non-invasive genetic test for hereditary prostate cancer, expanding its prostate cancer diagnostic offerings. The test, which uses a simple saliva sample, aims to provide insights into a patient's risk of developing prostate cancer, disease progression, and response to therapies. This addition is in line with National Comprehensive Cancer Network (NCCN) guidelines and is covered by Medicare and many commercial insurance plans. CEO Michael K. McGarrity believes this will contribute to the company's revenue and growth in the latter half of the year.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:02 pm

NCNA

NuCana has been granted U.S. Patent #11925658 for 'Phosphoramidate Derivatives for Use in the Treatment of Cancer,' covering treatments for leukemia, prostate, lung, and breast cancers, especially in resistant cases.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:00 pm

GOOG

GOOGL

LCID

Lucid Group Inc (LCID) is in a trademark dispute with Gravity Technologies, backed by Alphabet Inc (GOOG, GOOGL), over the name of its Gravity SUV. Gravity Technologies, which operates EV charging stations and previously ran an electric taxi fleet, filed a petition for cancellation against Lucid's vehicle trademark, citing potential consumer confusion. Lucid, facing a significant stock decline and reduced production estimates, is fighting the petition, despite the potential high costs and impact on its trademarks.

Portfolio Pulse from Chris Katje

March 12, 2024 | 7:38 pm

NVDA

NYCB

Citadel's Ken Griffin revealed that his hedge fund invested in New York Community Bancorp (NYCB) earlier this month, citing the investment was made because the price was right. Additionally, Griffin commented on the artificial intelligence (AI) sector, noting that while it's uncertain where we are in the journey of AI, Nvidia (NVDA) appears to be leading the field.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 7:38 pm

ENPH

FSLR

NOVA

RUN

SEDG

Solar stocks are trading lower after a Bloomberg report indicated that US solar factories might not be constructed due to cheaper imports from China, rendering subsidies insufficient.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 7:35 pm

MSFT

SONY

Former PlayStation executive Shawn Layden highlighted the financial risks of exclusivity for video games with budgets over $200M, advocating for broader releases to maximize player base and revenue. Microsoft Corp. and Sony Group Corp. are moving towards releasing some exclusive titles on rival platforms, reflecting a shift in strategy to adapt to the high costs of game development and the need to reach a wider audience. Peter Moore, a former Xbox executive, also supported this view, suggesting that releasing exclusive titles on rival platforms could significantly increase intellectual property value.

Portfolio Pulse from Franca Quarneti

March 12, 2024 | 7:05 pm

FTXL

PSI

Wedbush analyst Matt Bryson maintained Micron Technology Inc (NASDAQ:MU) with an Outperform rating and raised the price target from $95 to $103, citing strong DRAM and NAND pricing. Micron is expected to exceed its initial guidance for the quarterly earnings report on March 20, due to higher retail, spot, and forward contract prices. Bryson predicts DRAM contract Average Selling Prices (ASPs) to increase by nearly 20% in Q1, with NAND contracts performing even stronger. Despite a cautious outlook for the second half of the year, Micron's fiscal 2025 EPS estimates have been modestly increased. Micron's advancements in High Bandwidth Memory (HBM) and its competitive position in DRAM and NAND technologies suggest a strong outlook. Invesco Semiconductors ETF (NYSE:PSI) and First Trust Nasdaq Semiconductor ETF (NASDAQ:FTXL) are mentioned as ways to gain exposure to Micron.

Portfolio Pulse from Anusuya Lahiri

March 12, 2024 | 6:58 pm